Eu Ivdr Eu Ivd Class B On The Market ๐Ÿ‡ฉ๐Ÿ‡ช Germany

Acetylcholine Receptor Autoantibodies (ARAb) RRA

IBL International GmbH ยท ๐Ÿ‡ฉ๐Ÿ‡ช Germany
Devices (same UDI-DI)
3
Certificates
0
Countries
32
Notified Bodies
0

Basic Information

Primary DI
04049325033542
Basic UDI-DI Code
4049325IVR06020001BQZ
Reference
30221148
Device Types
Single use
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market
Manufacturer
IBL International GmbH

Additional Description

The Acetylcholine autoantibody radio receptor assay is intended for the semiquantitative determination of autoantibodies against the acetylcholine receptor in adult human serum and EDTA plasma. The measurement of highly specific autoantibodies against the acetylcholine receptor (AChr) is appropriate as an aid for diagnosis of myasthenia gravis (MG), a rare but long-term muscle disease leading to muscle weakness of varying severity. In diagnostics, the determination of autoantibodies against the acetylcholine receptor is used as the first screening tool in patients with suspected Myasthenia Gravis disease, as in around 80% of MG patients autoantibodies against AChR are detectable (seropositive MG). Furthermore determination of autoantibodies provides information concerning (patho-) physiological state of the patient. For definition of myasthenic subgroup, such as early-onset MG, late-onset MG, thymoma-associated or MuSK-associated MG, further diagnostic investigation is necessary. Subgroups will not be defined using this assay. Acetylcholine receptor from human muscle is used as antigen in this radio receptor assay. The receptors are labelled with 125I-alpha-bungarotoxin, which binds the receptors most specifically and almost irreversible. Autoantibodies present in the patientยดs serum or plasma attach to the labelled receptors. The resulting immune complexes are precipitated with anti-human IgG. The amount of radioactivity of the sediment is directly proportional to the concentration of acetylcholine receptor autoantibodies of the sample. The assay requires general purpose laboratory instruments and consumables such as gamma counter, vortexer and pipettes to execute the test. The manual kit assay test instructions must be strictly adhered to and verified by the laboratory. Test results are calculated from a standard curve and compared to defined cut-off. The test kit is intended for professional laboratory.

CND Nomenclature Codes

Code Description
W0102109022 ACETYLCHOLIN RECEPTOR ANTIBODIES

Available In Countries

๐Ÿ‡ฆ๐Ÿ‡น Austria ๐Ÿ‡ง๐Ÿ‡ช Belgium ๐Ÿ‡ง๐Ÿ‡ฌ Bulgaria ๐Ÿ‡จ๐Ÿ‡พ Cyprus ๐Ÿ‡จ๐Ÿ‡ฟ Czechia ๐Ÿ‡ฉ๐Ÿ‡ช Germany ๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark ๐Ÿ‡ช๐Ÿ‡ช Estonia ๐Ÿ‡ฌ๐Ÿ‡ท Greece ๐Ÿ‡ช๐Ÿ‡ธ Spain ๐Ÿ‡ซ๐Ÿ‡ฎ Finland ๐Ÿ‡ซ๐Ÿ‡ท France ๐Ÿ‡ญ๐Ÿ‡ท Croatia ๐Ÿ‡ญ๐Ÿ‡บ Hungary ๐Ÿ‡ฎ๐Ÿ‡ช Ireland ๐Ÿ‡ฎ๐Ÿ‡ธ Iceland ๐Ÿ‡ฎ๐Ÿ‡น Italy ๐Ÿ‡ฑ๐Ÿ‡ฎ Liechtenstein ๐Ÿ‡ฑ๐Ÿ‡น Lithuania ๐Ÿ‡ฑ๐Ÿ‡บ Luxembourg ๐Ÿ‡ฑ๐Ÿ‡ป Latvia ๐Ÿ‡ฒ๐Ÿ‡น Malta ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands ๐Ÿ‡ณ๐Ÿ‡ด Norway ๐Ÿ‡ต๐Ÿ‡ฑ Poland ๐Ÿ‡ต๐Ÿ‡น Portugal ๐Ÿ‡ท๐Ÿ‡ด Romania ๐Ÿ‡ธ๐Ÿ‡ช Sweden ๐Ÿ‡ธ๐Ÿ‡ฎ Slovenia ๐Ÿ‡ธ๐Ÿ‡ฐ Slovakia ๐Ÿ‡น๐Ÿ‡ท Tรผrkiye ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom

Related Devices

The Basic UDI-DI associated with this device has 3 devices in total. Below are some other devices sharing the same Basic UDI-DI.

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all